RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma
Fangfang Jiao(Shanghai Medical College of Fudan University), Rui Guo(Shanghai Medical College of Fudan University), Chris Jones(Institute of Cancer Research), Hongjie Shen(Soochow University), Gensheng Yang(Pharmaceutical Biotechnology (Czechia)), Chen He(St. Jude Children's Research Hospital), Yujiang Geno Shi(Brigham and Women's Hospital), Yang Shi(Boston Children's Hospital), Yong‐Chun Yu(Fudan University), Jamie N. Anastas(Baylor College of Medicine), Jiajun Cai(Fudan University), Ze Li(Bristol Royal Infirmary), Tingting Liu(Tianjin University of Traditional Chinese Medicine), Fei Lan(Fudan University), Ying Mao(Huashan Hospital), Yanhui Xu(Shanghai Medical College of Fudan University), Wenqi Xu(Fudan University), Suzanne J. Baker(St. Jude Children's Research Hospital)
Cited by 34
Related Papers
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
|Science|1989|2.1k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657